• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Miris Holding

26.40 SEK

+8.20 %

Less than 1K followers

MIR

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+8.20 %
+0.76 %
-30.88 %
-13.46 %
-19.24 %
-30.53 %
-81.09 %
-96.52 %
-99.95 %

Miris Holding is a biotechnology company that develops analytical instruments and consumables for human breast milk and fluids. The company has a particular focus on analyzing milk to provide proper nutrition to premature infants. The products are sold under separate brands and include a complete set of services and consumables. Miris operates on a global level, with headquarters based in Uppsala.

Read more
Market cap
35.18M SEK
Turnover
10.9K SEK
Revenue
17.47M
EBIT %
-22.84 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release6/2/2026, 6:40 AM

Miris Holding: University of Michigan investerar i ytterligare ett Miris HMA®

Miris Holding
Press release5/28/2026, 2:33 PM

Kommuniké från årsstämman i Miris Holding AB

Miris Holding
Regulatory press release5/28/2026, 12:00 PM

Miris Holding: Kvartalsrapport 1 2026

Miris Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/27/2026, 10:05 AM

Miris Holding: Ny USA-order bekräftar ökad aktivitet på marknaden för Miris HMA®

Miris Holding
Press release5/25/2026, 6:40 AM

Fortsatt starkt förtroende för Miris HMA® - ytterligare svensk neonatalvårdsavdelning återinvesterar

Miris Holding
Press release5/21/2026, 6:40 AM

Miris Holding: Ännu ett nordiskt sjukhus väljer att återinvestera i Miris HMA®

Miris Holding
Press release5/18/2026, 6:48 AM

Miris Holding: Massey University investerar i Miris HMA®

Miris Holding
Press release5/15/2026, 6:42 AM

Miris Holding: Ny order stärker Miris position på den tyska marknaden

Miris Holding
Press release4/30/2026, 9:03 AM

Miris Holding AB Årsredovisning 2026

Miris Holding
Press release4/22/2026, 6:42 AM

Kallelse till Årsstämma i Miris Holding AB

Miris Holding
Intervju med Miris Holdings VD under SCF:s 17:e Kapitalmarknadsdag Life Science
Video3/19/2026, 7:05 AM by
Jesper Hagman

Intervju med Miris Holdings VD under SCF:s 17:e Kapitalmarknadsdag Life Science

Miris Holding presenterade vid Stockholm Corporate Finance 17:e kapitalmarknadsdagar Life Science 2026. Vi intervjuade VD Camilla Myhre Sandberg om den marknadspotential som finns, varför konkurrensen är begränsad och vilka fokusområden Miris prioriterar under 2026.

Miris Holding
Miris Holding, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026
Webcast3/18/2026, 8:00 AM

Miris Holding, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026

Miris Holding
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars
Webcast3/18/2026, 7:00 AM

Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars

Välkommen att lyssna på Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars.

Miris HoldingDevyser DiagnosticsOrtomaNextCell PharmaSaniona
Press release3/16/2026, 9:10 AM

Miris Holding: Östersunds sjukhus återinvesterar i Miris HMA®

Miris Holding
Press release3/11/2026, 1:01 PM

Miris Holding: UZ Leuven investerar i Miris HMA® - första installationen i Belgien

Miris Holding
Press release2/26/2026, 3:14 PM

Miris Holding: Miris meddelar nytt datum för årsstämma 2026 samt offentliggörande av delårsrapport för första kvartalet 2026

Miris Holding
Press release2/11/2026, 11:49 AM

Miris Holding: Mount Sinai New York investerar i Miris HMA®

Miris Holding
Regulatory press release2/11/2026, 7:40 AM

Miris Holding AB: Bokslutskommuniké 2025

Miris Holding
Press release12/19/2025, 7:45 AM

Miris Holding: Miris AB Signs Distribution Agreement with Almazar Medical Corp to Expand Its Presence in the Middle East

Miris Holding
Press release12/19/2025, 7:45 AM

Miris Holding: Miris AB tecknar distributionsavtal med Almazar Medical Corp för att utöka sin närvaro i Mellanöstern

Miris Holding